Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-06-06
1998-11-24
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514381, 514524, 514539, 514619, 514620, 514640, 514824, 514825, 514863, 514886, 514887, 514916, 548252, 558418, 560 35, 562440, A61K 3141, A61K 31275, A61K 3119, A61K 31165
Patent
active
058407588
ABSTRACT:
Compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein Y is selected from halogen, alkyl, and haloalkyl; n is 0, 1, 2, or 3; A is selected from (a) optionally substituted alkylene, (b) optionally substituted cycloalkylene, (c) optionally substituted cycloalkylene wherein one or two of the carbon atoms is replaced with one or two heteroatoms independently selected from O, S, and N, (d) optionally substituted alkenylene and (e) ##STR2## X is absent or is alkylene; Z is selected from (a) hydrogen, (b) COM wherein M is selected from --OR.sup.4, --NR.sup.6 R.sup.7, and a pharmaceutically acceptable metabolically cleavable group, (c) --OR.sup.2, (d) tetrazolyl, (e) --CH(OR.sup.2)--CH.sub.2 OR.sup.8, (f) --CH(OR.sup.2)--CH.sub.2 --CH.sub.2 OR.sup.8, (g) --CH(OR.sup.2)--CH(OR.sup.8)--CH.sub.2 OR.sup.9, and (h).dbd.N--OR.sup.2 ; and R.sup.1 is selected from hydrogen, alkyl, and optionally substituted phenyl, are prostaglandin biosynthesis inhibitors and are useful in the treatment of inflammatory disease states. Also disclosed are prostaglandin inhibiting compositions, a method of inhibiting prostaglandin biosynthesis in a mammal.
REFERENCES:
patent: 5446067 (1995-08-01), Benoit et al.
Brooks Clint D. W.
Kolasa Teodozyj
Lee Wendy
Stewart Andrew O.
Abbott Laboratories
O'Sullivan Peter
Yang Frank Z.
LandOfFree
Oxime derivatives of fenamates as inhibitors of prostaglandin bi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime derivatives of fenamates as inhibitors of prostaglandin bi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivatives of fenamates as inhibitors of prostaglandin bi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702662